Osteopontin as a Biomarker for Coronary Artery Disease
Georgia R. Layton(University of Leicester), Mustafa Zakkar(University of Leicester), Riyaz Somani(University of Leicester), Alice Copperwheat(University Hospitals of Leicester NHS Trust), Sanjay Bhandari(University Hospitals of Leicester NHS Trust), Ibrahim Antoun(Kettering General Hospital), Z.U. Khan(Lancaster University), G. André Ng(NIHR Leicester Cardiovascular Biomedical Research Unit)
Cited by 5
Related Papers
Complement C3 is a novel plasma clot component with anti-fibrinolytic properties
|Diabetes and Vascular Disease Research|2012|80
Ethnic differences in cardiovascular risk factors in healthy Caucasian and South Asian individuals with the metabolic syndrome
|Journal of Thrombosis and Haemostasis|2007|69
Machine learning in sudden cardiac death risk prediction: a systematic review
|EP Europace|2022|62
Procainamide infusion in the evaluation of unexplained cardiac arrest: From the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER)
|Heart Rhythm|2014|53
Dermatoglyphic interpretation of dental caries and its correlation to salivary bacteria interactions: An in vivo study
|Journal of Indian Society of Pedodontics and Preventive Dentistry|2009|43